help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castells, S.
Right arrow Articles by Marx, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castells, S.
Right arrow Articles by Marx, S. J.

Journal of Clinical Endocrinology & Metabolism, Vol 63, 252-256, Copyright © 1986 by Endocrine Society

ARTICLES

Severely deficient binding of 1,25-dihydroxyvitamin D to its receptors in a patient responsive to high doses of this hormone

S Castells, F Greig, MA Fusi, L Finberg, S Yasumura, UA Liberman, C Eil and SJ Marx

A 1.6-yr-old Hispanic boy with sparse hair, muscle weakness, severe growth retardation, and rickets was found to have hypocalcemia, secondary hyperparathyroidism, and high circulating 1,25- dihydroxyvitamin D [1,25-(OH)2D] levels. One year of treatment with a high dose of 1,25-(OH)2D3 (20 micrograms, orally, daily) resulted in marked subjective and radiological improvement; there was a parallel improvement in serum calcium, phosphorus, PTH, alkaline phosphatase, and osteocalcin concentrations. Soluble extracts from cultured skin fibroblasts did not bind [3H]1,25-(OH)2D3 using standard methods. To evaluate the possibility of receptors with abnormally low affinity, we tested for binding with [3H]1,25-(OH)2D3 concentrations higher than those usually used. In one experiment, there was a suggestion of low affinity binding. Hormone receptors with abnormally low affinity for 1,25-(OH)2D may explain this patients resistance to 1,25-(OH)2D. Therapy to maintain extremely high serum 1,25-(OH)2D3 concentrations markedly improved mineral homoeostasis, but did not affect the hair disorder.


This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
B. N Ames, I. Elson-Schwab, and E. A Silver
High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms
Am. J. Clinical Nutrition, April 1, 2002; 75(4): 616 - 658.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
V. Umpaichitra, W. Bastian, and S. Castells
Hypocalcemia in Children: Pathogenesis and Management
Clinical Pediatrics, June 1, 2001; 40(6): 305 - 312.
[Abstract] [PDF]

Home page
 Endocr. Rev.Home page
P. J. Malloy, J. W. Pike, and D. Feldman
The Vitamin D Receptor and the Syndrome of Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets
Endocr. Rev., April 1, 1999; 20(2): 156 - 188.
[Abstract] [Full Text]

Home page
 ScienceHome page
M. Hughes, P. Malloy, D. Kieback, R. Kesterson, J. Pike, D Feldman, and B. O'Malley
Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets
Science, December 23, 1988; 242(4886): 1702 - 1705.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society